Hematologic Malignancy
Myeloid Leukemia
CI-CAN-00001251Explore in graph →
Hematologic862 active trials22 approved drugs599 evidence items
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001251Explore in graph →
Clinical trials
3,528 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (617)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00038675 | Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate | completed | N/A | 125 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 4, 2022 | clinicaltrials |
| NCT02592447 | Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention | completed | N/A | 48 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 16, 2021 |
| clinicaltrials |
| NCT03881826 | Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia(MicroAML) | completed | N/A | 60 | Université Catholique de LouvainOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT02559557 | Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects | completed | N/A | 38 | City of Hope Medical CenterOTHER | 1 | Aug 12, 2021 | clinicaltrials |
| NCT00988013 | Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies(IM-TMI) | completed | N/A | 14 | University of Illinois at ChicagoOTHER | 1 | Jun 14, 2021 | clinicaltrials |
| NCT01768845 | Unrelated Umbilical Cord Blood (UBC)Transplantation | completed | N/A | 34 | West Virginia UniversityOTHER | 1 | Jun 14, 2021 | clinicaltrials |
| NCT00536601 | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | completed | N/A | 174 | Roswell Park Cancer InstituteOTHER | 1 | Apr 22, 2021 | clinicaltrials |
| NCT02809222 | Plasmatic L-AScorbic Acid in MYelodyplastic Syndroms and Controls(PLASMYC) | completed | N/A | 138 | University Hospital, ToursOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT01288222 | Selecting a Favorable KIR Donor in Unrelated HCT for AML | completed | N/A | 506 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT01807091 | Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome | completed | N/A | 17 | University of WashingtonOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT04617145 | Aerobic Versus Resistive Training on Functional Capacity in Acute Myeloid Leukemia | completed | N/A | 60 | Cairo UniversityOTHER | 1 | Nov 5, 2020 | clinicaltrials |
| NCT02410252 | Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies | completed | N/A | 25 | Massachusetts General HospitalOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT04595955 | Effects of a Digital Patient Platform (CMyLife) for Patients With Chronic Myeloid Leukemia (CML) on Information Provision, Patient Empowerment, Medication Compliance, Guideline Adherence and Quality of Life | completed | N/A | 99 | Radboud University Medical CenterOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT01869777 | Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia | completed | N/A | 102 | Wake Forest University Health SciencesOTHER | 1 | Aug 13, 2020 | clinicaltrials |
| NCT01611298 | Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR(TAR) | completed | N/A | 7 | Robert KranceOTHER | 1 | Apr 21, 2020 | clinicaltrials |
| NCT02487069 | Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy | completed | N/A | 876 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT00342316 | Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia | completed | N/A | 340 | Vastra Gotaland RegionOTHER_GOV | 9 | Jan 27, 2020 | clinicaltrials |
| NCT00014235 | Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies | completed | N/A | 160 | Fred Hutchinson Cancer CenterOTHER | 3 | Jan 21, 2020 | clinicaltrials |
| NCT02719821 | Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation | completed | N/A | 17 | University of Wisconsin, MadisonOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT02955043 | Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery | completed | N/A | 39 | University of Wisconsin, MadisonOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT00856388 | Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders | completed | N/A | 62 | Roswell Park Cancer InstituteOTHER | 1 | Nov 13, 2019 | clinicaltrials |
| NCT03442452 | AML Electronic Decision Aid | completed | N/A | 20 | Duke UniversityOTHER | 1 | Oct 15, 2019 | clinicaltrials |
| NCT00005799 | Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer | completed | N/A | 55 | Fred Hutchinson Cancer CenterOTHER | 2 | Sep 10, 2019 | clinicaltrials |
| NCT00179764 | Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) | completed | N/A | 68 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 1 | Aug 30, 2019 | clinicaltrials |
| NCT01519596 | Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy | completed | N/A | 70 | Wake Forest University Health SciencesOTHER | 1 | Aug 16, 2019 | clinicaltrials |
| NCT02602587 | Study of Dendrogenin A / Oxysterols Balance Between Healthy Volunteers and Acute Myeloid Leukemia Patients(OXYLAM) | completed | N/A | 37 | University Hospital, ToulouseOTHER | 1 | May 13, 2019 | clinicaltrials |
| NCT01499147 | Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies | completed | N/A | 100 | University of Illinois at ChicagoOTHER | 1 | Nov 8, 2018 | clinicaltrials |
| NCT00789256 | Low Dose Melphalan and Bortezomib for AML and High-Risk MDS | completed | N/A | 26 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Oct 24, 2018 | clinicaltrials |
| NCT02877277 | Epigenetics, Vitamin C and Abnormal Hematopoiesis - Pilot Study(EVITA-Pilot) | completed | N/A | 20 | Rigshospitalet, DenmarkOTHER | 1 | Sep 24, 2018 | clinicaltrials |
| NCT01872819 | Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay | completed | N/A | 16 | University of WashingtonOTHER | 1 | Jul 11, 2018 | clinicaltrials |
| NCT01053494 | Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer | completed | N/A | 80 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT02101983 | Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) | completed | N/A | 11 | University of RochesterOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT01804101 | Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia | completed | N/A | 48 | Fred Hutchinson Cancer CenterOTHER | 1 | May 25, 2018 | clinicaltrials |
| NCT02121418 | Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm | completed | N/A | 12 | University of WashingtonOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT01779882 | Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT | completed | N/A | 72 | University Hospital, Basel, SwitzerlandOTHER | 1 | Mar 2, 2018 | clinicaltrials |
| NCT00445744 | Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome | completed | N/A | 52 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 2, 2018 | clinicaltrials |
| NCT00167167 | Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia | completed | N/A | 40 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT01831232 | Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes | completed | N/A | 24 | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT03280290 | Transplant T CD4+ CCR7+ In Hematopoietic Stem Cells Allograft(CCR7-CD4-DPL) | completed | N/A | 20 | University Hospital, LilleOTHER | 1 | Sep 12, 2017 | clinicaltrials |
| NCT02099266 | Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment | completed | N/A | 15 | University of Kansas Medical CenterOTHER | 1 | Jun 12, 2017 | clinicaltrials |
| NCT00112593 | Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer | completed | N/A | 5 | Fred Hutchinson Cancer CenterOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT02160600 | Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial | completed | N/A | 124 | All India Institute of Medical SciencesOTHER | 1 | Apr 27, 2017 | clinicaltrials |
| NCT00408681 | Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant(GVHD) | completed | N/A | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT00726934 | The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients | completed | N/A | 149 | Indiana UniversityOTHER | 1 | Feb 8, 2017 | clinicaltrials |
| NCT02860793 | Role of PTK-7 in Acute Myeloid Leukemias(LAM-PTK7) | completed | N/A | 10 | Institut Paoli-CalmettesOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT02103530 | Early Response Assessment of Induction Chemotherapy in Acute Myeloid Leukemia Patients Using F-18 FLT PET/CT | completed | N/A | 10 | The Catholic University of KoreaOTHER | 1 | Feb 2, 2016 | clinicaltrials |
| NCT02007863 | Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia | completed | N/A | 2 | University of MiamiOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00088543 | Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant | completed | N/A | 60 | Genzyme, a Sanofi CompanyINDUSTRY | 2 | Mar 18, 2015 | clinicaltrials |
| NCT00187096 | Natural Killer (NK) Cell Transplantation for AML | completed | N/A | 49 | St. Jude Children's Research HospitalOTHER | 1 | Jun 19, 2014 | clinicaltrials |
| NCT01233921 | Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer | completed | N/A | 6 | Martin, PaulOTHER | 1 | Apr 2, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Jan 4, 2022source: clinicaltrials